A split face randomized controlled trial comparing 1,064 nm Q-switched Nd-YAG laser and modified Kligman’s formulation in patients with melasma in darker skin.

In Dermatology
by ClinOwl October 4, 2020

No randomized studies compared the efficacy and safety of modified Kligman’s triple combination (TC) with 1,064 nm Q-switched Nd-YAG laser (QSNYL) in melasma in darker skin.To compare the efficacy and safety […]

U.S. Burden of Skin and Subcutaneous Diseases Increasing

Can dermatology employers require employees to receive the COVID-19 vaccine?

THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

Expression of retinoid receptors in hand eczema.

S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

A split face randomized controlled trial comparing 1,064 nm Q-switched Nd-YAG laser and modified Kligman’s formulation in patients with melasma in darker skin.